Novartis Investigative Site

Utrecht, The Netherlands 3508 GA

0 studies enrolling now · 6 studies all time

What they study most

Anklyosing Spondylitis, Atopic Dermatitis, Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), Graft-versus-host Disease (GVHD), Healthy Volunteers, Hemodialysis, Kidney Transplantation, Netherton Syndrome, Renal Replacement Therapy, Renal Transplantation, Solid Tumors

Studies at this site

• A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) — Completed
• CCFZ533X2201 - PoC Study in de Novo Renal Transplantation — Completed
• Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors — Completed
• A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome — Completed
• 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis — Completed
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) — Completed